BACK
portfolio company

Alveo

sector
Diagnostics & Imaging
 •
Care Delivery
 •
status
Active
Initial Investment
2021
location
USA
Molecular diagnostic platform for rapid detection of infectious diseases.
company overview

Alveo Technologies' be.well platform is a portable, app-connected molecular diagnostic system that delivers laboratory-quality results for human, animal, and plant pathogens at the point of need.

social media
Related NEWS